COMMUNIQUÉS West-GlobeNewswire

enGen Recognized for Digital Health Innovation in 2025 MedTech Breakthrough Awards Program
08/05/2025
Prestigious International Annual Awards Program Honors Standout Digital Health & Medical Technology Products and Companies LOS ANGELES, May 08, 2025 (GLOBE NEWSWIRE) -- MedTech Breakthrough , an independent market [...]
Cullinan Therapeutics Provides Corporate Update and Reports First Quarter 2025 Financial Results
08/05/2025
Company received approval from European Medicines Agency (EMA) for CLN-978; Phase 1 study in active, difficult-to-treat rheumatoid arthritis to initiate in Q2 2025 CLN-978 expands into Sjögren’s disease; Phase 1 study [...]
Shock Top: A Bold Rebrand for a Craft Beer Icon
08/05/2025
A fresh take on the iconic brand coincides with a bold new marketing campaign PORTLAND, Ore., May 08, 2025 (GLOBE NEWSWIRE) -- Shock Top , a craft beer icon and brand by Tilray Brands, Inc. company (NASDAQ: TLRY and TSX [...]
Cartesian Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
08/05/2025
Initiation of Phase 3 AURORA trial of Descartes-08 in myasthenia gravis expected in 2Q25; deep and sustained benefits observed through Month 12 after a single course of therapy in Phase 2b trial Preliminary data from [...]
Werewolf Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
08/05/2025
– WTX-124 Phase 1/1b clinical trial on track for data readouts and interactions with the FDA in the second half of the year – – First patient dosed in the Phase 1b/2 clinical trial of WTX-330, seeking to build on the [...]
Conavi Medical’s Novasight Hybrid™ System Named “Product Innovation of the Year” at 2025 Minnesota Manufacturing Awards
08/05/2025
Award recognizes Novasight Hybrid™ System’s significant advance in intracoronary imaging technology TORONTO, May 08, 2025 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (TSXV: CNVI; OTCQB: CNVIF) (“Conavi Medical” or the “ [...]
ProQR Announces First Quarter 2025 Operating and Financial Results
08/05/2025
Axiomer™ ADAR-mediated RNA editing pipeline advancing across liver and CNS programs, with CTA filing on track for Q2 2025 for lead program AX-0810 targeting NTCP for Cholestatic diseases Strengthened leadership with [...]
Seamless Therapeutics Expands Board of Directors with Appointment of Alvin Shih
08/05/2025
Dresden, Germany, and Lexington, MA, May 8, 2025 – Seamless Therapeutics , today announced the appointment of Alvin Shih, M.D., M.B.A., as an Independent Director to its Board. Dr. Shih is an experienced drug developer [...]
GH Research Reports First Quarter 2025 Financial Results and Provides Business Updates
08/05/2025
Primary endpoint met in Phase 2b trial with GH001 in TRD demonstrating -15.5 Point placebo-adjusted MADRS reduction Full response to the IND hold on track for submission in mid-2025 Cash, cash equivalents, other [...]
BiomX to Host First Quarter 2025 Financial Results Conference Call and Webcast on May 15, 2025
08/05/2025
NESS ZIONA, Israel, May 08, 2025 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a clinical-stage company advancing novel natural and engineered phage therapies that target specific [...]
HilleVax Reports First Quarter 2025 Financial Results and Highlights Recent Company Progress
08/05/2025
$159.5 million of cash, cash equivalents and marketable securities as of March 31, 2025 The company is exploring the potential for continued development of its norovirus vaccine candidates in adults as well as business [...]
LENSAR Reports First Quarter 2025 Results and Provides Business Update
08/05/2025
14 ALLY Robotic Laser Cataract Systems™ (“ALLY Systems”) placed in 1Q 2025 with an additional backlog of 24 systems pending installation as of March 31, 2025 34% Revenue growth over the first quarter 2024 and 22% [...]
Invivyd to Host First Quarter 2025 Financial Results and Corporate Update Conference Call on May 15, 2025
08/05/2025
WALTHAM, Mass., May 08, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD), a biopharmaceutical company devoted to delivering protection from serious viral infectious diseases, today announced that it will host a [...]
Clearside Biomedical to Report First Quarter 2025 Financial Results on Wednesday, May 14, 2025
08/05/2025
ALPHARETTA, Ga., May 08, 2025 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD) (“Clearside” or the “Company”), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye [...]
Axogen, Inc. Reports 2025 First Quarter Financial Results
08/05/2025
ALACHUA, Fla. and TAMPA, Fla., May 08, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today reported [...]
Wellgistics Health Secures $50M Credit Facility and Launches XRP-Powered Payment Initiative
08/05/2025
Tampa, FL, May 08, 2025 (GLOBE NEWSWIRE) -- Wellgistics Health, Inc. (NASDAQ: WGRX), a technology-first pharmaceutical distribution and healthcare infrastructure company, today announced a new initiative to pioneer the [...]
Altimmune Presents New Analyses Predicting High Rates of MASH Resolution on Biopsy following Pemvidutide Treatment at the EASL International Liver Congress™
08/05/2025
MASH Resolution Index (MASHResInd) model highly predictive of MASH resolution GAITHERSBURG, Md., May 08, 2025 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company developing [...]
Wave Life Sciences Reports First Quarter 2025 Financial Results and Provides Business Update
08/05/2025
Dosing complete in the first two cohorts of INLIGHT trial in obesity of WVE-007 (INHBE siRNA), designed to induce healthy weight loss by reducing fat without impacting muscle; clinical data on track for 2H 2025 Dosing [...]
Xilio Therapeutics Announces Pipeline and Business Updates and First Quarter 2025 Financial Results
08/05/2025
Updated Phase 2 data to be presented at ASCO for vilastobart, a tumor-activated, Fc-enhanced, anti-CTLA-4, in combination with atezolizumab in patients with metastatic microsatellite stable colorectal cancer (MSS CRC) [...]

Pages